Archive-CNS Summit Podcast

Hear how Dr. Amy Abernethy, Principle Deputy Commissioner and current Acting CIO of the FDA sees the role of technology, including AI and RWE in the drug development landscape. Fireside chat featuring: - Dr. Amy Abernethy, the Principle Deputy Commissioner and current Acting CIO of the FDA - Dr Amir Kalali, Chief Curator of CNS Summit Learn more about CNS Summit and to read full bios on each speaker, head to CNSSummit.org. Follow us on Twitter (@cnssummit). Hear and subscribe to all the episodes in this series on Health Podcast Network.

Hear how Ali Parsa, CEO of Babylon Health sees the future of enabling accessible and affordable health service to every person on earth using quantum computing, 5G networks, IoT, prescriptive analytics, augmented reality and robotics. This episode was recorded on the main stage at the 2019 CNS Summit in Boca Raton, Florida. Panel discussion featuring: - Ali Parsa, CEO of Babylon Health - Dr Amir Kalali, Chief Curator of CNS Summit - Dr Junaid Bajwa, Global Lead for Strategic Alliances and Solutions for the Global Digital Centre of Excellence at Merck Learn more about CNS Summit and to read full bios on each speaker, head to CNSSummit.org. Follow us on Twitter (@cnssummit). Hear and subscribe to all the episodes in this series on Health Podcast Network.

Hear how Jessica Mega, Chief Medical and Scientific Officer at Verily, sees the intersection of life science, healthcare and technology through research programs, such as Project Baseline. Panel Conversation featuring: - Jessica Mega, Chief Medical and Scientific Officer at Verily - Dr. Reed Tuckson, Managing Director of Tuckson Health Connections - Dr Amir Kalali, Chief Curator of CNS Summit Learn more about CNS Summit and to read full bios on each speaker, head to CNSSummit.org. Follow us on Twitter (@cnssummit). Hear and subscribe to all the episodes in this series on Health Podcast Network.

Hear how MIT Professor Dina Katabi sees the future of neurodegenerative diseases like Parkinson's and Huntington's, mood disorders and GI and Immune system diseases with applications like wearables and AI. Fireside Chat Featuring: - Dina Katabi, Andrew & Erna Viterbi Professor of Electrical Engineering and Computer Science at MIT - Dr Amir Kalali, Chief Curator of CNS Summit This was recorded on the main stage at the 2019 CNS Summit which was held in Boca Raton, Florida. To learn more about CNS Summit and read full bios on each speaker, head to CNSSummit.org. Follow us on Twitter @cnssummit. Hear and subscribe to all the episodes in this series on Health Podcast Network.

Hear how George Goldsmith and Ekaterina Malievskaia from COMPASS Pathways are working to bring innovation psychedelic drug applications for depression. Learn what what this means for patients, regulators and trials. Panel Conversation Featuring: - George Goldsmith Co-Founder and Executive Chairman of COMPASS Pathways - Dr Ekaterina Malievskaia, Research and Development at COMPASS - Jane Metcalf, Founder of Neo.Life - Dr Amir Kalali, Chief Curator of CNS Summit This was recorded on the main stage at the 2019 CNS Summit which was held in Boca Raton, Florida. To learn more about CNS Summit and read full bios on each speaker, head to CNSSummit.org. Follow us on Twitter (@cnssummit). Hear and subscribe to all the episodes in this series on Health Podcast Network.

This is a special episode of a webinar that was recorded on Friday, May 8, 2020. In this recording, we hear from Dr. Amy Abernethy, Principal Deputy Commissioner and Acting CIO of the FDA, as she speaks with Dr Amir Kalali, Chief Curator of CNS Summit. Drs. Abernethy and Kalali discuss: How Covid-19 is impacting drug development How the FDA is aligning and responding to the pandemic Unexpected ways the pandemic may influence clinical research and medicine For more podcasts like this, be sure to subscribe to the CNS Summit Podcast on Apple Podcasts, Google Podcasts or Spotify, and you can also find us on Health Podcast Network at HealthPodcastNetwork.com Learn more about the CNS Summit and follow us on Twitter (@cnssummit) to find out more about upcoming events, news and announcements.

Eric is currently Chief Science Officer at Datavant and Visiting Scientist at the Department of Biomedical Informatics at Harvard Medical School. Most recently, Eric was Senior Vice President Data Sciences at Takeda R&D. Previously, Eric was the Executive Director of the Center for Biomedical Informatics and the Countway Library of Medicine at Harvard Medical School. Eric served as the CIO and Chief Scientist (Informatics) at the U.S. Food and Drug Administration. Eric has also served as Senior Bioinformatics Advisor at Precision for Medicine, as the Chair of the ASCO CancerLinQ technology advisory and on the Editorial Board of the DIA flagship journal, Journal of Regulatory Science and Innnovation Prior to FDA, Eric was Senior Vice President of R&D IT at J&J Pharmaceuticals R&D. Eric also held the posts of Vice President R&D Informatics, Vice President and CIO, Director of Research IT, Assistant Director and Director of Drug Discovery Research at J&J. Eric has a PhD in chemical and biochemical engineering from Drexel University. Learn more about the CNS Summit and follow us on Twitter (@cnssummit). Listen to this episode on Health Podcast Network.

Deborah Dunsire is the CEO and President of Lundbeck. Prior to that, she was the CEO and President of FORUM Pharmaceuticals and the CEO and President at Millennium Pharmaceuticals. She has more than 25 years of scientific, clinical, operational and commercial experience, and proven leadership in the biological and pharmaceutical industry. Dr. Dunsire holds a Doctor of Medicine from the University of Witwatersand, Johannesburg, South Africa. Learn more about the CNS Summit and follow us on Twitter (@cnssummit). Listen to this episode on Health Podcast Network.